-
, characterization and optimization of molecules with drug-like properties, and the development of novel therapeutic concepts. The group follows a highly integrated and multidisciplinary approach, including drug
-
trapping and analysis using state-of-the-art nanopore experiments. About the Project Our group has pioneered the development of the Nanopore Electro-Osmotic Trap (NEOtrap), a groundbreaking technique that
-
-bleaching of the fluorescent dyes involved, which ends the experiment prematurely, rendering many biological questions inaccessible. To bypass this limitation, our group has developed DyeCycling/FRET, where
-
clinical scientists to advance our understanding of health and disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 800
-
career development are located in Basel. Basel provides a high standard of living and a rich and varied cultural atmosphere.
-
Your position Our group conducts research at the intersection of artificial intelligence (AI) and pediatric healthcare, developing AI and machine learning (ML) methods to address real-world clinical
-
from this research inform the development of new diagnostics, treatments, and vaccines against malaria, tuberculosis, schistosomiasis, Chagas and other neglected tropical diseases. Within the Parasite